HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sang Soo Kang Selected Research

UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase

1/2018O-linked N-acetylglucosamine transferase enhances secretory clusterin expression via liver X receptors and sterol response element binding protein regulation in cervical cancer.
7/2016O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sang Soo Kang Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 07/2003
11Seizures (Absence Seizure)
04/2013 - 02/2003
8Glioma (Gliomas)
01/2022 - 11/2010
8Neoplasm Metastasis (Metastasis)
01/2020 - 04/2009
7Hypoxia (Hypoxemia)
01/2022 - 10/2002
7Ischemia
12/2013 - 09/2002
5Ganglion Cysts (Ganglion)
01/2022 - 06/2003
5Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2021 - 07/2016
5Inflammation (Inflammations)
10/2020 - 06/2012
5Diabetic Retinopathy (Retinopathy, Diabetic)
12/2017 - 12/2002
4Pain (Aches)
10/2019 - 03/2009
4Glioblastoma (Glioblastoma Multiforme)
05/2018 - 02/2010
4Body Weight (Weight, Body)
03/2018 - 12/2013
3Lung Neoplasms (Lung Cancer)
04/2022 - 01/2017
3Diabetes Mellitus
01/2021 - 06/2003
3Type 2 Diabetes Mellitus (MODY)
08/2020 - 03/2018
3Carcinogenesis
01/2018 - 02/2014
3Reperfusion Injury
12/2017 - 10/2003
3Obesity
09/2015 - 06/2012
3Stomach Neoplasms (Stomach Cancer)
11/2013 - 04/2009
3Drug Resistant Epilepsy
12/2006 - 10/2004
2Low Tension Glaucoma
01/2022 - 01/2021
2Glaucoma
01/2022 - 12/2017
2Hematoma
04/2021 - 07/2012
2Brain Neoplasms (Brain Tumor)
05/2018 - 09/2012
2Macular Degeneration (Age-Related Maculopathy)
12/2017 - 12/2016
2Neuroinflammatory Diseases
10/2017 - 12/2011
2Insulin Resistance
01/2016 - 09/2015
2Memory Disorders (Memory Loss)
01/2016 - 06/2012
2Acute Kidney Injury (Acute Renal Failure)
12/2013 - 06/2009
2Neuroblastoma
08/2013 - 09/2006
2Status Epilepticus (Complex Partial Status Epilepticus)
06/2012 - 11/2010
2Infarction (Infarctions)
10/2010 - 10/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2006 - 10/2003
2Brain Injuries (Brain Injury)
10/2005 - 10/2003
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022
1Cataract (Cataracts)
01/2022

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2003
10Kainic Acid (Kainate)IBA
04/2013 - 02/2003
8Retinaldehyde (Retinal)IBA
01/2022 - 03/2003
6ResveratrolIBA
01/2022 - 12/2011
5Messenger RNA (mRNA)IBA
01/2019 - 07/2003
4Pharmaceutical PreparationsIBA
10/2021 - 10/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 07/2015
4Glucose (Dextrose)FDA LinkGeneric
08/2020 - 09/2015
4ClusterinIBA
01/2018 - 06/2003
4Streptozocin (Streptozotocin)FDA Link
10/2017 - 06/2003
4Small Interfering RNA (siRNA)IBA
01/2017 - 11/2010
4TristetraprolinIBA
12/2016 - 01/2015
4thiamine triphosphorate (TTP)IBA
12/2016 - 01/2015
4Ethanol (Ethyl Alcohol)IBA
04/2016 - 05/2005
4rho Guanine Nucleotide Dissociation Inhibitor betaIBA
03/2015 - 04/2009
3Trifluoperazine (Stelazine)FDA LinkGeneric
04/2022 - 01/2017
3Antipsychotic Agents (Antipsychotics)IBA
04/2022 - 01/2017
3Complementary DNA (cDNA)IBA
03/2021 - 12/2002
3RNA (Ribonucleic Acid)IBA
03/2021 - 01/2016
3Hypoglycemic Agents (Hypoglycemics)IBA
08/2020 - 01/2014
3Caspase 3 (Caspase-3)IBA
12/2017 - 11/2010
3TransferasesIBA
10/2017 - 07/2017
3Calmodulin (Calcium-Dependent Activator Protein)IBA
01/2017 - 10/2008
3CalciumIBA
01/2017 - 10/2008
3Caffeine (No Doz)FDA LinkGeneric
01/2017 - 02/2010
3Tacrolimus (Prograf)FDA LinkGeneric
06/2014 - 10/2008
3Cisplatin (Platino)FDA LinkGeneric
11/2013 - 03/2011
3Glutamic Acid (Glutamate)FDA Link
04/2013 - 03/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2011 - 10/2002
3Anticonvulsants (Antiepileptic Drugs)IBA
12/2006 - 10/2004
3Betaxolol (Kerlon)FDA LinkGeneric
10/2003 - 09/2002
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2021
2Therapeutic UsesIBA
01/2022 - 01/2016
2CytokinesIBA
10/2019 - 01/2014
2Analgesics (Analgesic Drugs)IBA
10/2019 - 03/2009
2AcetylglucosamineIBA
01/2019 - 01/2017
2Metformin (Glucophage)FDA LinkGeneric
01/2019 - 10/2017
2UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA
01/2018 - 07/2016
2NFATC Transcription FactorsIBA
10/2017 - 05/2014
2Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
01/2017 - 02/2010
2Oncogene Proteins (Oncogene Protein)IBA
01/2017 - 07/2016
2NF-kappa B (NF-kB)IBA
09/2015 - 12/2011
2Plasminogen Activators (Plasminogen Activator)IBA
01/2015 - 12/2011
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2015 - 12/2011
2CalcineurinIBA
06/2014 - 10/2008
2Carbon Nanotubes (Carbon Nanotube)IBA
10/2013 - 09/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2013 - 03/2011
2deoxyuridine triphosphateIBA
05/2012 - 11/2010
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2012 - 11/2010
2CaspasesIBA
03/2011 - 06/2009
2Neuroprotective AgentsIBA
10/2009 - 10/2003
2Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2006 - 10/2002
2Nitric Oxide Synthase (NO Synthase)IBA
02/2006 - 10/2002
1Proteoglycans (Proteoglycan)IBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1Peptides (Polypeptides)IBA
10/2021
1GalactosamineIBA
10/2021
1LipopolysaccharidesIBA
10/2021

Therapy/Procedure

7Ketogenic Diet
12/2011 - 02/2003
4Therapeutics
12/2013 - 10/2004
2Intraperitoneal Injections
10/2021 - 10/2017
2Anesthesia
01/2021 - 01/2015
1Trabeculectomy (Trabeculoplasty)
01/2022